Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer

Cisplatin‐based chemoradiotherapy is considered standard treatment for unresectable locally advanced non‐small‐cell lung cancer (LA‐NSCLC). This study examined two regimens of chemotherapy in concurrent chemoradiation. Eligible patients with unresectable, radically irradible LA‐NSCLC were randomized...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Med
Asıl Yazarlar: Shimokawa, Tsuneo, Yamada, Kazuhiko, Tanaka, Hiroshi, Kubota, Kaoru, Takiguchi, Yuichi, Kishi, Kazuma, Saito, Haruhiro, Hosomi, Yukio, Kato, Terufumi, Harada, Daijiro, Otani, Sakiko, Kasai, Takashi, Nakamura, Yoichi, Misumi, Toshihiro, Yamanaka, Takeharu, Okamoto, Hiroaki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Clinical Cancer Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7877366/
https://ncbi.nlm.nih.gov/pubmed/33319495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3641
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller